Akari Therapeutics Plc - ADR (AKTX) Company Profile & Statistics

Akari Therapeutics Plc - ADR
AKTX
(Nasdaq - US)
N/A
1.49
-0.21 (-12.35%)
in:usd•As of: May 02, 2024 15:45 UTC -4
Open
1.66
High
1.66
Low
1.48

About Akari Therapeutics Plc - ADR

CEO

Rachelle Jacques

Headquarters

75/76 wimpole street

london, x0 w1g 9rt, united kingdom

Auditor

BDO USA, LLP

Employees

Share Holders

N/A

Website

www.akaritx.com

Industry

biotechnology

Sector

health technology

Company Overview

Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.

Akari Therapeutics Plc - ADR Statistics

Valuation Measures

Market Capitalization ²	11.80M
Enterprise Value	7.96M
Enterprise Value/EBITDA (ttm)	-0.63
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	-154.13%
Return on Assets (ttm)	N/A

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-12.58M
Net Income Avi to Common (ttm)	-12.42M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	0.99
52-Week Change	-59.18%
S&P500 52-Week Change	24.86%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	7.92M
Dividend Yield	0.00%
Float ⁴	3.03M
% Held by Insiders	61.80%
% Held by Institutions	5.06%

Balance Sheet

Total Cash (mrq)	3.85M
Total Cash Per Share (mrq)	0.49
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	N/A
Quick Ratio (mrq)	0.95%
Book Value Per Share (mrq)	N/A

Cash Flow

Operating Cash Flow Per Share (ytd)	N/A
Free Cash Flow (ytd)	0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Akari Therapeutics Plc - ADR

Trade With A Regulated Broker